Fairvalue-Calculator Fairvalue-Calculator
EN DE

Alumis Inc (ALMS) Fair Value & Analysis

Healthcare · US · Market cap $2.6B

Price$24.51
Fair Value$10.98
Upside-55.2%
Quality91/100
Evidence: Low Range $8.24 – $13.73

Fair value as of: Jun 24, 2026

Analysis

Alumis Inc (ALMS) currently trades at $24.51, while our model-based Fair Value estimate is $10.98 — implying the stock looks roughly 55.2% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. Alumis Inc. was incorporated in 2021 and is headquartered in South San Francisco, California.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Alumis Inc (ALMS) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $10.98 versus a price of $24.51 — about −55% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ALMS?
Our 21-model fair value for Alumis Inc is $10.98 (as of Jun 24, 2026), built from audited fundamentals. The current price is $24.51.
What is the quality score of ALMS?
Alumis Inc has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.